$FTRE

Morais Mark A. sold $79K of FTRE

Morais Mark A. (Chief Operating Officer) sold 4,674 shares of Fortrea Holdings Inc. (FTRE) at $16.82 on 2026-06-10.

Original reporting
SEC EDGAR · Morais Mark A.
Published Jun 12, 2026, 8:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 12, 2026, 8:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$FTRE
Bearish
medium confidence
Mentioned
$FTRE
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FTREBearishLow
01

Why it matters

Provides a fresh, primary datapoint on insider behavior, but does not introduce new company fundamentals or external catalysts.

02

Market read

Traders may monitor insider activity as a sentiment input, but this specific disclosure is unlikely to drive a durable repricing without additional news.

03

What to watch

Check whether other insiders also sold/bought around the same window and whether there are concurrent corporate events (earnings, guidance, contracts) not mentioned here.

Relevance 3/10Novelty 8/10Timing: Filed 2026-06-12; sale executed 2026-06-10.

Background

The article is an SEC EDGAR Form 4 disclosure of an insider’s open-market sale by Fortrea’s COO.

Company-level read

Ticker impact

$FTREBearishMedium confidence
Context

Fortrea COO Mark Morais sold 4,674 shares in an open-market transaction on 2026-06-10 for ~$78.6K, per Form 4.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-driven and short-lived.

Evidence & confidence

The filing is a primary-source insider transaction, but it is not tied to new fundamentals (no guidance, deal, or regulatory action) and the size is modest versus typical institutional flows.

Market effects

No direct sector read-through; this is an issuer-specific insider transaction without stated operational change.

None indicated.

None indicated.

Counterpoint

Insider sales can be pre-planned for diversification or tax/vesting liquidity needs; the filing notes no 10b5-1 plan, but that still doesn’t imply bearish company outlook by itself.

Key entities

  • Fortrea Holdings Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Morais Mark A.

    Chief Operating Officer who sold shares.

Related articles

$FTREHighAI 9/10

Fortrea Q2 Earnings Call Highlights

"The environment has become more supportive, but our results are not simply the result of market recovery," Thakral said, attributing the performance to changes in commercial execution, including improved global coordination, a sharper focus on opportunities where the company can compete effectively and a clearer approach to serving distinct customer segments. Thakral said Fortrea's clinical pharmacology services business was a particular area of strength.

$FTREMedAI 8/10

Fortrea (NASDAQ:FTRE) Reports Strong Q2 CY2026, Full

Fortrea Holdings (NASDAQ:FTRE) reported Q2 CY2026 revenue of $678.2 million, down 4.5% year over year but 4.7% above market expectations, according to the company. Full-year revenue guidance was $2.66 billion at the midpoint, 1.8% above analysts’ estimates. Non-GAAP EPS was $0.23, 27.2% above consensus.

$FTREMed

Fortrea Holdings Inc. (FTRE): Results of Operations and Financial Condition

Fortrea Holdings Inc. (FTRE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991-pressreleasedat.htm EX-99.1 Document Exhibit 99.1 Fortrea Reports Second Quarter 2026 Results Four consecutive quarters of execution to drive commercial, operational and financial excellence Increases full-year guidance Highlights For the three months ended J

$FTREMedAI 8/10

Fortrea (NASDAQ:FTRE) Trading 10.5% Higher – Should You Buy?

Fortrea Holdings (NASDAQ:FTRE) rose 10.5% in mid-day trading Thursday, reaching $17.20 and last at $17.27, after closing at $15.63. Volume was 886,991 shares, down 42% vs. average. Analysts cited include price targets from $14 to $20. On May 5, Fortrea reported $0.16 EPS vs $0.03 expected and $636.5M revenue vs $628.5M.